Pleshkan Victor Victorovich | Institute of Molecular Genetics
Doctor of Philosophy (Biology)
without academic rank
Division of IMG:
Laboratory of onkogenomics
Main research interests
Development of gene therapy of anticancer drugs, a tumor-specific expression of therapeutic transgenes, regulation of gene expression, promoters, DNA methylation. Cancerogenesis, markers, and gene therapy. Cytotoxic cells of the immune system and their receptors. Construction of vectors, chimeric proteins.
Head of 2nd year of study Postgraduate.
- Pleshkan V.V., Vinogradova T.V., Sverdlov E.D. “Methylation of the prominin 1 TATA-less main promoters and tissue specificity of their transcript content” Biochim Biophys Acta 1779 (2008) 599-605.
- Alekseenko I.V., Pleshkan V.V., Kopantzev E.P., Stukacheva E.A., Chernov I.P., Vinogradova T.V., Sverdlov E.D. "Activity of the upstream component of tandem TERT/survivin promoters depends on features of the downstream component" PLoS ONE, 2012;7(10):e46474. doi: 10.1371/journal.pone.0046474. Epub 2012 Oct 3.**
- Alekseenko IV, Snezhkov EV, Chernov IP, Pleshkan VV, Potapov VK, Sass AV, Monastyrskaya GS, Kopantzev EP, Vinogradova TV, Khramtsov YV, Ulasov AV, Rosenkranz AA, Sobolev AS, Bezborodova OA, Plyutinskaya AD, Nemtsova ER, Yakubovskaya RI, Sverdlov ED. Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer. J Transl Med. 2015;13:433. doi: 10.1186/s12967-015-0433-0. Epub 2015 Mar 4.